Oncology Institute Inc. CW-22STLNWPreferred / convertible
13F holders, Q3 2024 (September 30)15holders −3
0new positions
3sold out
1famous investor
$0.02avg. 13F price*
At the end of Q3 2024, 15 institutions reported holding Oncology Institute Inc. CW-22 (STLNW) in their 13F filings, down 3 from Q2 2024. 0 opened new positions and 3 sold out. The largest holders were Deerfield Management Company, L.P. ($25K), Walleye Capital LLC ($8K) and Davidson Kempner Capital Management LP ($6K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Oncology Institute Inc. CW-22
- Filed as
- THE ONCOLOGY INSTITUTE INC (Q3 2024)
- CUSIP
- 68236X118
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $43K |
All 13F filers, Q2 2024 → Q3 2024: 1,652,809 shares sold, net −1,652,809 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Deerfield Management Company, L.P. | — | No change | 1,250,000 | $25K |
| Walleye Capital LLC | — | No change | 393,545 | $8K |
| Davidson Kempner Capital Management LP | — | No change | 318,710 | $6K |
| FreeGulliver LLC | — | No change | 193,101 | $4K |
| Man Group plc | — | No change | 88,824 | $2K |
| Healthcare of Ontario Pension Plan Trust Fund | — | No change | 87,500 | $2K |
| Cowen and Company, LLC | — | Reduce -0.5% | 86,726 | $2K |
| Wolverine Asset Management LLC | — | No change | 74,720 | $1K |
| Two Sigma Investments, LP | — | No change | 30,000 | $600 |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 25,000 | $500 |
| Alpine Global Management, LLC | — | No change | 25,024 | $500 |
| Citadel Advisors | — | Reduce -0.6% | 17,808 | $356 |
| UBS Group AG | — | Reduce -30.8% | 6,083 | $122 |
| Clear Street LLC | — | Reduce -20.9% | 1,893 | $38 |
| Bank of America Corp. | — | Reduce -44.5% | 499 | $10 |
"% of holder's portfolio" is STLNW's weight in each manager's 13F, not the share of Oncology Institute Inc. CW-22 the manager owns.